Skip to main content
. 2017 Aug 10;8(42):72652–72665. doi: 10.18632/oncotarget.20194

Table 2. IC50 values and RIs of Bel7402 and Bel7402/5-FU cells treated with different chemotherapeutic agents.

Drugs Bel7402 IC50(μmol/L) Bel7402/5-FU
IC50(μmol/L) RI
5-fluorouracil 38.3±0.7 455.2±3.1** 11.7±0.3
Cisplatin 3.9±0.8 102.1±5.2** 31.5±7.0
Oxaliplatin 8.9±0.4 118.5±2.2** 14.3±0.8

IC50 values and RI were determined by the CCK-8 method. Data are expressed as means ± SD. **P < 0.01 versus the parental cells.

HHS Vulnerability Disclosure